Cargando…

Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma

BACKGROUND: α-Dystroglycan is the highly glycosylated component of the dystrophin-glycoprotein complex (DGC) that binds with high-affinity to extracellular matrix (ECM) proteins containing laminin-G-like (LG) domains via a unique heteropolysaccharide [-GlcA-beta1,3-Xyl-alpha1,3-](n) called matriglyc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beltrán, Daniel, Anderson, Mary E., Bharathy, Narendra, Settelmeyer, Teagan P., Svalina, Matthew N., Bajwa, Zia, Shern, John F., Gultekin, Sakir H., Cuellar, Marco A., Yonekawa, Takahiro, Keller, Charles, Campbell, Kevin P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500046/ https://www.ncbi.nlm.nih.gov/pubmed/31054580 http://dx.doi.org/10.1186/s13395-019-0195-0

Ejemplares similares

POMK regulates dystroglycan function via LARGE1-mediated elongation of matriglycan
por: Walimbe, Ameya S, et al.
Publicado: (2020)

Defining the Extracellular Matrix of Rhabdomyosarcoma
por: Lian, Xiaolei, et al.
Publicado: (2021)

Identification of Matriglycan by Dual Exoglycosidase Digestion of α-Dystroglycan
por: Chandel, Ishita, et al.
Publicado: (2023)

Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane
por: Yoshida-Moriguchi, Takako, et al.
Publicado: (2015)

Involvement of abnormal dystroglycan expression and matriglycan levels in cancer pathogenesis
por: Quereda, Cristina, et al.
Publicado: (2022)

Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma
por: Bharathy, Narendra, et al.
Publicado: (2017)

N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy
por: Okuma, Hidehiko, et al.
Publicado: (2023)

Structural basis for matriglycan synthesis by the LARGE1 dual glycosyltransferase
por: Katz, Michael, et al.
Publicado: (2022)

Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth
por: Lu, Pei J., et al.
Publicado: (2020)

Lassa Fever Virus Binds Matriglycan—A Polymer of Alternating Xylose and Glucuronate—On α-Dystroglycan
por: Joseph, Soumya, et al.
Publicado: (2021)

Cell surface glycan engineering reveals that matriglycan alone can recapitulate dystroglycan binding and function
por: Sheikh, M. Osman, et al.
Publicado: (2022)

NFκB signaling in alveolar rhabdomyosarcoma
por: Cleary, Megan M., et al.
Publicado: (2017)

Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
por: Bharathy, Narendra, et al.
Publicado: (2019)

The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition
por: Praissman, Jeremy L, et al.
Publicado: (2016)

Exogenous laminin exhibits a unique vascular pattern in the brain via binding to dystroglycan and integrins
por: Ruan, Jingsong, et al.
Publicado: (2022)

Structural basis of laminin binding to the LARGE glycans on dystroglycan
por: Briggs, David C., et al.
Publicado: (2016)

Loss of α-Dystroglycan Laminin Binding in Epithelium-derived Cancers Is Caused by Silencing of LARGE
por: de Bernabé, Daniel Beltrán-Valero, et al.
Publicado: (2009)

High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of α-dystroglycan
por: Bigotti, Maria Giulia, et al.
Publicado: (2021)

IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma
por: Berlow, Noah E., et al.
Publicado: (2018)

Linker molecules between laminins and dystroglycan ameliorate laminin-α2–deficient muscular dystrophy at all disease stages
por: Meinen, Sarina, et al.
Publicado: (2007)

Laminin-induced Clustering of Dystroglycan on Embryonic Muscle Cells: Comparison with Agrin-induced Clustering
por: Cohen, Monroe W., et al.
Publicado: (1997)

LARGE Expression Augments the Glycosylation of Glycoproteins in Addition to α-Dystroglycan Conferring Laminin Binding
por: Zhang, Zhen, et al.
Publicado: (2011)

Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy
por: Kanagawa, Motoi, et al.
Publicado: (2009)

Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease
por: Voglmeir, Josef, et al.
Publicado: (2011)

Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma
por: Miller, Michael R., et al.
Publicado: (2015)

α-Dystroglycan Is a Laminin Receptor Involved in Extracellular Matrix Assembly on Myotubes and Muscle Cell Viability
por: Montanaro, Federica, et al.
Publicado: (1999)

Characterization of dystroglycan binding in adhesion of human induced pluripotent stem cells to laminin-511 E8 fragment
por: Sugawara, Yumika, et al.
Publicado: (2019)

biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies
por: Gumlaw, Nathan, et al.
Publicado: (2020)

An atypical expression of core α-Dystroglycan and Laminin-α2 in skin fibroblasts of patients with congenital muscular dystrophies
por: Sabry, Sahar, et al.
Publicado: (2023)

EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma
por: Randolph, Matthew E., et al.
Publicado: (2017)

Plexin-B2 and Semaphorins Do Not Drive Rhabdomyosarcoma Proliferation or Migration
por: Karki, Anju, et al.
Publicado: (2022)

A High Throughput Screen Identifies Chemical Modulators of the Laminin-Induced Clustering of Dystroglycan and Aquaporin-4 in Primary Astrocytes
por: Noël, Geoffroy, et al.
Publicado: (2011)

Volasertib preclinical activity in high-risk hepatoblastoma
por: Kats, Dina, et al.
Publicado: (2019)

Functional Glycosylation of Dystroglycan Is Crucial for Thymocyte Development in the Mouse
por: Liou, Li-Ying, et al.
Publicado: (2010)

A dystroglycan ligand in the brain
por: Jegalian, Karin
Publicado: (2001)

M. leprae interacts with the human epidermal keratinocytes, neonatal (HEKn) via the binding of laminin-5 with α-dystroglycan, integrin-β1, or -β4
por: Jin, Song-Hyo, et al.
Publicado: (2019)

The conserved WW-domain binding sites in Dystroglycan C-terminus are essential but partially redundant for Dystroglycan function
por: Yatsenko, AS, et al.
Publicado: (2009)

Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma
por: Kikuchi, Ken, et al.
Publicado: (2013)

An evaluation of the evolution of the gene structure of dystroglycan
por: Brancaccio, Andrea, et al.
Publicado: (2017)

Structural flexibility of human α‐dystroglycan
por: Covaceuszach, Sonia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g00bc9shoil2tvl495n5ib4oev